Healthy volunteers needed to compare two forms of a cholesterol drug
NCT ID NCT07470125
First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 2 times
Summary
This study checks if a new version of a drug (YHP2511) is absorbed into the body the same way as the original (YHP2511A). About 60 healthy adults aged 19 to 55 will take a single dose of each version on separate days. The goal is to see if the two versions are bioequivalent, meaning they work the same in the body.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
H Plus Yangji Hospital
Seoul, 08779, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Radioactive tracer reveals the Body's journey of an experimental drug
- Can music lessons rewire Teens' social media habits?
- Can a Finger-Prick replace the lab draw? a device puts accuracy to the test
- Avocado at breakfast: a secret weapon for blood sugar and fullness?
- Sound waves as medicine: ultrasound may tame inflammation without drugs
- Broader pneumonia shield: new vaccine tested in children